Sorafenib
-
- Applikation
- Inhibition (Inh)
- Verwendungszweck
- Raf-1 kinase inhibitor
- Reinheit
- >99 %
- Chemical Name
- 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-methylbenzenesulfonic acid
- Formel
- C21H16ClF3N4O3
- Löslichkeit
- Soluble inDMSO (200mg/ml) or ethanol (3mg/ml)
-
-
- Kommentare
-
Source: Synthetic.
Appearance: Off white powder - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Powder
- Vorsichtsmaßnahmen
- Classification: Not a hazardous substance or mixture. Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
- Handhabung
- Classification: Not a hazardous substance or mixture. Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
- Lagerung
- -20 °C
-
- Molekulargewicht
- 464.8
- CAS-Nummer
- 284461-73-0
-